Tvardi Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Tvardi Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Tvardi Therapeutics Inc.
Rating: 2.06858325
Author: Trendlyne DVM scores

about

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This p...

33.00 0.16 (0.49%)

Near 52W High of $34.31

1,625

XNAS Volume

XNAS 11 Sep, 2025 10:31 AM (EDT)

Not Eligible

Expensive Valuation

5.3 / 100

Technically Bullish

77.4 / 100

1Yr Price target upside is 73%

7 analysts

Tvardi Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tvardi Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This p...

Near 52W High of $34.31

SWOT Analysis

Tvardi Therapeutics Inc Live Price Chart